Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic DermatitisPing Liu, Jianzhong Zhang, Yan Zhao et al.|Chinese Medical Journal|2016Cited by 110
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trialYan Zhao, Bo Chen, Liming Wu et al.|Chinese Medical Journal|2023Cited by 40
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing Li, Bin Yang et al.|BioDrugs|2024Cited by 16